Pandora L Wander1, Edward J Boyko2, Karin Hevner3, Viraj J Parikh4, Mahlet G Tadesse5, Tanya K Sorensen3, Michelle A Williams6, Daniel A Enquobahrie7. 1. Department of Medicine, University of Washington, Seattle, WA, USA; VA Puget Sound Health Care System, Seattle, WA, USA. Electronic address: lwander@u.washington.edu. 2. Department of Medicine, University of Washington, Seattle, WA, USA; VA Puget Sound Health Care System, Seattle, WA, USA. 3. Center for Perinatal Studies, Swedish Medical Center, Seattle, WA, USA. 4. Department of Epidemiology, University of Washington, Seattle, WA, USA. 5. Department of Mathematics and Statistics, Georgetown University, Washington, DC, USA. 6. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 7. Center for Perinatal Studies, Swedish Medical Center, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Abstract
AIMS: Epigenetic regulators, including microRNAs (miRNAs), are implicated in type 2 diabetes, but evidence linking circulating miRNAs in pregnancy and risk of gestational diabetes (GDM) is sparse. Potential modifiers, including pre-pregnancy overweight/obesity and offspring sex, are unexamined. We hypothesized that circulating levels of early-mid-pregnancy (range 7-23weeks of gestation) candidate miRNAs are related to subsequent development of GDM. We also hypothesized that miRNA-GDM associations might vary by pre-pregnancy body-mass index (ppBMI) or offspring sex. METHODS: In a case-control analysis (36GDM cases/80 controls) from the Omega study, a prospective cohort study of pregnancy complications, we measured early-mid-pregnancy plasma levels of 10miRNAs chosen for potential roles in pregnancy course and complications (miR-126-3p, -155-5p, -21-3p, -146b-5p, -210-3p, -222-3p, -223-3p, -517-5p, -518a-3p, and 29a-3p) using qRT-PCR. Logistic regression models adjusted for gestational age at blood draw (GA) were fit to compare circulating miRNAs between cases and controls. We repeated analyses among overweight/obese (ppBMI≥25kg/m2) or lean (ppBMI<25kg/m2) women, and women with male or female offspring separately. RESULTS: Mean age was 34.3years (cases) and 32.9years (controls). GA-adjusted miR-155-5p (β=0.260/p=0.028) and -21-3p (β=0.316/p=0.005) levels were positively associated with GDM. MiR-146b-5p (β=0.266/p=0.068) and miR-517-5p (β=0.196/p=0.074) were borderline. Associations of miR-21-3p and miR-210-3p with GDM were observed among overweight/obese but not lean women. Associations of six miRNAs (miR-155-5p, -21-3p, -146b-5p, -223-3p, -517-5p, and -29a-3p) with GDM were present only among women carrying male fetuses (all p<0.05). CONCLUSIONS: Circulating early-mid-pregnancy miRNAs are associated with GDM, particularly among women who are overweight/obese pre-pregnancy or pregnant with male offspring. This area has potential to clarify mechanisms underlying GDM pathogenesis and identify at-risk mothers earlier in pregnancy. Published by Elsevier B.V.
AIMS: Epigenetic regulators, including microRNAs (miRNAs), are implicated in type 2 diabetes, but evidence linking circulating miRNAs in pregnancy and risk of gestational diabetes (GDM) is sparse. Potential modifiers, including pre-pregnancy overweight/obesity and offspring sex, are unexamined. We hypothesized that circulating levels of early-mid-pregnancy (range 7-23weeks of gestation) candidate miRNAs are related to subsequent development of GDM. We also hypothesized that miRNA-GDM associations might vary by pre-pregnancy body-mass index (ppBMI) or offspring sex. METHODS: In a case-control analysis (36GDM cases/80 controls) from the Omega study, a prospective cohort study of pregnancy complications, we measured early-mid-pregnancy plasma levels of 10miRNAs chosen for potential roles in pregnancy course and complications (miR-126-3p, -155-5p, -21-3p, -146b-5p, -210-3p, -222-3p, -223-3p, -517-5p, -518a-3p, and 29a-3p) using qRT-PCR. Logistic regression models adjusted for gestational age at blood draw (GA) were fit to compare circulating miRNAs between cases and controls. We repeated analyses among overweight/obese (ppBMI≥25kg/m2) or lean (ppBMI<25kg/m2) women, and women with male or female offspring separately. RESULTS: Mean age was 34.3years (cases) and 32.9years (controls). GA-adjusted miR-155-5p (β=0.260/p=0.028) and -21-3p (β=0.316/p=0.005) levels were positively associated with GDM. MiR-146b-5p (β=0.266/p=0.068) and miR-517-5p (β=0.196/p=0.074) were borderline. Associations of miR-21-3p and miR-210-3p with GDM were observed among overweight/obese but not lean women. Associations of six miRNAs (miR-155-5p, -21-3p, -146b-5p, -223-3p, -517-5p, and -29a-3p) with GDM were present only among women carrying male fetuses (all p<0.05). CONCLUSIONS: Circulating early-mid-pregnancy miRNAs are associated with GDM, particularly among women who are overweight/obese pre-pregnancy or pregnant with male offspring. This area has potential to clarify mechanisms underlying GDM pathogenesis and identify at-risk mothers earlier in pregnancy. Published by Elsevier B.V.
Authors: Kirsten Riches; Aliah R Alshanwani; Philip Warburton; David J O'Regan; Stephen G Ball; Ian C Wood; Neil A Turner; Karen E Porter Journal: J Mol Cell Cardiol Date: 2014-06-10 Impact factor: 5.000
Authors: Jette Bork-Jensen; Camilla Scheele; Daniel V Christophersen; Emma Nilsson; Martin Friedrichsen; Denise S Fernandez-Twinn; Louise G Grunnet; Thomas Litman; Kim Holmstrøm; Birgitte Vind; Kurt Højlund; Henning Beck-Nielsen; Jørgen Wojtaszewski; Susan E Ozanne; Bente K Pedersen; Pernille Poulsen; Allan Vaag Journal: Diabetologia Date: 2014-11-19 Impact factor: 10.122
Authors: Baqer A Haider; Alexander S Baras; Matthew N McCall; Joshua A Hertel; Toby C Cornish; Marc K Halushka Journal: PLoS One Date: 2014-02-26 Impact factor: 3.240
Authors: Kristin D Gerson; Miriam J Haviland; Dayna Neo; Jonathan L Hecht; Andrea A Baccarelli; Kasey Jm Brennan; Alexandra E Dereix; Steven J Ralston; Michele R Hacker; Heather H Burris Journal: Epigenomics Date: 2020-08-18 Impact factor: 4.778
Authors: Sylvia E Badon; Alyson J Littman; Kwun Chuen Gary Chan; Mahlet G Tadesse; Patricia L Stapleton; Theo K Bammler; Tanya K Sorensen; Michelle A Williams; Daniel A Enquobahrie Journal: Epigenomics Date: 2018-10-16 Impact factor: 4.778
Authors: Pandora L Wander; Daniel A Enquobahrie; Theo K Bammler; James W MacDonald; Sengkeo Srinouanprachanh; Thanmai Kaleru; Dori Khakpour; Subbulaxmi Trikudanathan Journal: Mol Cell Endocrinol Date: 2022-07-14 Impact factor: 4.369
Authors: Mugdha V Joglekar; Wilson K M Wong; Fahmida K Ema; Harry M Georgiou; Alexis Shub; Anandwardhan A Hardikar; Martha Lappas Journal: Diabetologia Date: 2021-03-23 Impact factor: 10.122